How Antibody Discovery Services Are Shaping the Future of Drug Development
Introduction Every year, more than 100 new monoclonal antibody therapies enter clinical pipelines, reshaping the way we treat cancers, autoimmune disorders, and infectious diseases NIH. At the core of this progress lies a highly specialized process: antibody discovery services. These services provide scientists with the tools to identify, screen, and refine antibodies for therapeutic use. […]
How Antibody Discovery Services Are Shaping the Future of Drug Development Read More »









